BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/10/2021 12:09:57 PM | Browse: 436 | Download: 913
 |
Received |
|
2021-02-22 12:31 |
 |
Peer-Review Started |
|
2021-02-22 12:34 |
 |
To Make the First Decision |
|
|
 |
Return for Revision |
|
2021-04-19 17:13 |
 |
Revised |
|
2021-04-29 17:01 |
 |
Second Decision |
|
2021-07-22 03:06 |
 |
Accepted by Journal Editor-in-Chief |
|
|
 |
Accepted by Executive Editor-in-Chief |
|
2021-07-23 05:37 |
 |
Articles in Press |
|
2021-07-23 05:37 |
 |
Publication Fee Transferred |
|
|
 |
Edit the Manuscript by Language Editor |
|
2021-08-09 22:07 |
 |
Typeset the Manuscript |
|
2021-09-06 14:04 |
 |
Publish the Manuscript Online |
|
2021-09-10 12:09 |
ISSN |
1948-5204 (online) |
Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
Copyright |
© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. |
Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
Website |
http://www.wjgnet.com |
Category |
Oncology |
Manuscript Type |
Minireviews |
Article Title |
Evidence based tools to improve efficiency of currently administered oncotherapies for tumors of the hepatopancreatobiliary system
|
Manuscript Source |
Invited Manuscript |
All Author List |
Zoltan Herold, A Marcell Szasz and Magdolna Dank |
ORCID |
|
Funding Agency and Grant Number |
Funding Agency |
Grant Number |
UNKP-20-4-I New National Excellence Program of the Ministry for Innovation and Technology from the source of the National Research, Development and Innovation Fund |
|
|
Corresponding Author |
Magdolna Dank, MD, PhD, Professor, Division of Oncology, Department of Internal Medicine and Oncology, Semmelweis University, Tomo u. 25-29, Budapest H-1083, Hungary. dank.magdolna@med.semmelweis-univ.hu |
Key Words |
Hyperthermia induced; Carcinoma hepatocellular; Cholangiocarcinoma; Gallbladder neoplasms; Pancreatic neoplasms |
Core Tip |
Adjuvant hyperthermia is beneficial in hepatopancreatobiliary cancers due to its direct and indirect anti-tumoral effects. Higher response rate to treatment, longer survival, and improved laboratory and quality of life data has been observed in several randomized and observational clinical trials on various hyperthermia methods. The routine use of hyperthermia in cancer care has not emerged yet. In this review, the clinical data on hyperthermia in hepatopancreatobiliary tumors is summarized, focusing mainly on results that have the most clinical and research interest. |
Publish Date |
2021-09-10 12:09 |
Citation |
Herold Z, Szasz AM, Dank M. Evidence based tools to improve efficiency of currently administered oncotherapies for tumors of the hepatopancreatobiliary system. World J Gastrointest Oncol 2021; 13(9): 1109-1120 |
URL |
https://www.wjgnet.com/1948-5204/full/v13/i9/1109.htm |
DOI |
https://dx.doi.org/10.4251/wjgo.v13.i9.1109 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345